Want to join the conversation?
Pharma company $NVS reported positive results of Phase III EXPAND study. It showed that oral once-daily BAF312 (siponimod) significantly reduced risk of disability progression versus placebo in people with secondary progressive multiple sclerosis. This is a form of multiple sclerosis with continuous worsening of neurological function over time.
I haven’t seen a drop in banks like this in a long time. Looks like $WFC is still facing pressures from its sales practices scandal..!!
Helping President-elect's America first focus, $WMT set to create 10,000 retail jobs in the US in 2017.
Looks like Trump has his eyes on the $MON and Bayer merger next. He had a meeting with the CEOs and apparently got job promises from them.